PDD Holdings Announces Third Quarter 2024 Unaudited Financial Results
November 21, 2024 06:30 ET
|
PDD Holdings Inc.
DUBLIN and SHANGHAI, Nov. 21, 2024 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the third quarter ended...
Zymeworks Announces Participation in Upcoming Investor Conferences
November 21, 2024 06:05 ET
|
Zymeworks Inc.
VANCOUVER, British Columbia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...
Hooker Furnishings to Host Third Quarter Earnings Call December 5th
November 21, 2024 06:00 ET
|
Hooker Furnishings Corporation
MARTINSVILLE, Va., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) will present its fiscal 2025 third quarter financial results via teleconference and live...
Lotus Technology Reports Unaudited Third Quarter and First Nine Months 2024 Financial Results
November 21, 2024 06:00 ET
|
Lotus Technology Inc.
Over 7,600 vehicles delivered in the first nine months of 2024, a year-on-year increase of 136%Total revenue reached $653 million, more than doubled year-on-yearRevenue of intelligent driving business...
FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
November 21, 2024 06:00 ET
|
Zymeworks Inc.
Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2-positive BTC in the U.S.Ziihera received accelerated approval based on results including a 52% objective response...
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
November 21, 2024 06:00 ET
|
TG Therapeutics, Inc.
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number one on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing...
SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment
November 21, 2024 06:00 ET
|
SINTX Technologies, Inc.
Salt Lake City, UT, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials,...
Duluth Holdings Inc. to Report Third Quarter 2024 Financial Results on December 5
November 21, 2024 05:45 ET
|
Duluth Trading Company
MOUNT HOREB, Wis., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear,...
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
November 21, 2024 05:30 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
iQIYI Announces Third Quarter 2024 Financial Results
November 21, 2024 04:00 ET
|
iQIYI, Inc.
BEIJING, Nov. 21, 2024 (GLOBE NEWSWIRE) -- iQIYI, Inc. (Nasdaq: IQ) ("iQIYI" or the "Company"), a leading provider of online entertainment video services in China, today announced its unaudited...